Table 1

Demographics of all 80 mothers recruited to the breast milk trial

In trialIn trial
DomperidoneMetoclopramideNo trial dataTotal
Number31341580
Mean (SD)Mean (SD)Mean (SD)Mean (SD)
Mother's age (years)30.7 (5.6)31.9 (6.8)29.1 (7.0)30.9 (6.4)
Baby gestation (weeks)28.6 (4.0)27.84 (3.5)29.73 (3.9)28.48 (3.8)
Birth weight (kg)1.534 (0.922)1.233 (0.749)1.844 (1.227)1.464 (0.936)
First expressed (h)28.6 (14.7)29.8 (24.3)29.2 (21.1)29.2 (20.2)
Baby age when drug started (days)29.4 (26)27.5 (20.3)
N (%)N (%)N (%)N (%)
Partner29 (93.5%)33 (97%)14 (93.3%)76 (95%)
Primiparous22 (71%)23 (67.6%)8 (53.3%)53 (66.2%)
Previous breastfeeding7 (22.6%)8 (23.5%)5 (33.3%)20 (25%)
Smoker5 (16%)3 (8.8%)2 (13.3%)10 (12.5%)
Drinks alcohol5 (16%)3 (8.8%)2 (13.3%)10 (12.5%)
Infertility treatment3 (9.7%)7 (20.6%)2 (13.3%)12 (15%)
Polycystic ovary syndrome4 (13%)5 (14.7%)1 (6.7%)10 (12.5%)
Other endocrine disease1 (3.2%)2 (5.9%)1 (6.7%)4 (5%)
Breast changes (antenatal)24 (77.4%)28 (82.4%)13 (86.7%)65 (81.2%)
Emergency caesarean delivery15 (48.4%)20 (58.8%)7 (46.7%)42 (50.6%)
Singleton24 (77.4%)28 (82.4%)10 (66.7%)62 (77.5%)
Early skin-to-skin contact with the baby8 (25.8%)9 (26.5%)2 (13.3%)19 (23.8%)
Early breastfeed (within 1 h of delivery)5 (16%)5 (14.7%)1 (6.7%)11 (13.8%)
Given formula in the neonatal intensive care unit18 (58%)14 (41.2%)11 (73.3%)43 (53.8%)
Baby gender: males21 (68%)19 (56%)6 (40%)46 (57.5%)